Avalyn Pharmaceuticals position history
The shares of Avalyn Pharmaceuticals that DAVIDSON KEMPNER CAPITAL MANAGEMENT LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 23,000 shares, $757K, <0.01% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|